Published date: 8 July 2024

This notice was replaced on 8 July 2024

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 8 July 2024, last edited 16 August 2024)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Immune sera and immunoglobulins - 33651500

Location of contract

United Kingdom

Value of contract

£0

Procurement reference

CF-2451500D0O000000rwimUAA

Published date

8 July 2024

Closing date

13 August 2024

Closing time

1pm

Contract start date

1 May 2025

Contract end date

30 April 2029

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The provision of immunoglobulin products.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
Information about volumes for each lot is included in the Invitation to Offer documents.

More information

Attachments

Additional text

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: support-health@atamis.co.uk

About the buyer

Contact name

Chantal Jockel

Address

10 South Colonnade
London
E14 4PU
GB

Email

vmc.vaccines@ukhsa.gov.uk